• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑癌基因 TAp73 特异响应人正常成纤维细胞中 E2F 活性失调。

Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.

机构信息

Department of Molecular Virology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.

出版信息

Genes Cells. 2012 Aug;17(8):660-72. doi: 10.1111/j.1365-2443.2012.01617.x. Epub 2012 Jun 15.

DOI:10.1111/j.1365-2443.2012.01617.x
PMID:22702391
Abstract

Discrimination of oncogenic growth signals from normal growth signals is crucial for tumor suppression. The transcription factor E2F, the main target of pRB, plays central role in cell proliferation by activating growth-promoting genes. E2F also plays an important role in tumor suppression by activating growth-suppressive genes such as pro-apoptotic genes. The regulatory mechanism of the latter genes is not known in detail, especially in response to normal and oncogenic growth signals. E2F is physiologically activated by growth stimulation through phosphorylation of pRB. In contrast, upon dysfunction of pRB, a major oncogenic change, E2F is activated out of control by pRB, generating deregulated E2F activity. We show here that the tumor suppressor TAp73 gene, which can induce apoptosis independently of p53, responds to deregulated E2F activity, but not to physiological E2F activity induced by growth stimulation in human normal fibroblasts. We identified E2F-responsive elements (ERE73s) in TAp73 promoter that can specifically sense deregulated E2F activity. Moreover, RB1-deficient cancer cell lines harbored deregulated E2F activity that activated ERE73s and the TAp73 gene, which were suppressed by re-introduction of pRB. These results underscore the important role of deregulated E2F in activation of the TAp73 gene, a component of major intrinsic tumor suppressor pathways.

摘要

区分致癌生长信号和正常生长信号对于肿瘤抑制至关重要。转录因子 E2F 是 pRB 的主要靶标,通过激活促进生长的基因在细胞增殖中发挥核心作用。E2F 还通过激活促凋亡基因等生长抑制基因在肿瘤抑制中发挥重要作用。这些基因的调控机制尚不清楚,尤其是在应对正常和致癌生长信号时。E2F 通过 pRB 的磷酸化被生长刺激生理性激活。相比之下,在 pRB 功能障碍(一种主要的致癌变化)时,E2F 会失控激活,产生失调的 E2F 活性。我们在这里表明,肿瘤抑制因子 TAp73 基因可以独立于 p53 诱导细胞凋亡,它响应失调的 E2F 活性,但对人正常成纤维细胞中生长刺激诱导的生理性 E2F 活性没有反应。我们在 TAp73 启动子中鉴定了 E2F 反应元件(ERE73s),它们可以特异性感知失调的 E2F 活性。此外,RB1 缺陷型癌细胞系中存在失调的 E2F 活性,该活性激活了 ERE73s 和 TAp73 基因,而 pRB 的重新引入则抑制了它们的活性。这些结果强调了失调的 E2F 在激活 TAp73 基因中的重要作用,该基因是主要内在肿瘤抑制途径的组成部分。

相似文献

1
Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts.抑癌基因 TAp73 特异响应人正常成纤维细胞中 E2F 活性失调。
Genes Cells. 2012 Aug;17(8):660-72. doi: 10.1111/j.1365-2443.2012.01617.x. Epub 2012 Jun 15.
2
Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts.在人正常成纤维细胞中鉴定由失调的E2F特异性激活的新靶基因。
Genes Cells. 2015 Sep;20(9):739-57. doi: 10.1111/gtc.12268. Epub 2015 Jul 23.
3
E1A activates transcription of p73 and Noxa to induce apoptosis.E1A激活p73和Noxa的转录以诱导细胞凋亡。
J Biol Chem. 2005 Feb 18;280(7):5945-59. doi: 10.1074/jbc.M406661200. Epub 2004 Nov 29.
4
p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.p53 失活通过 E2F-1 介导的转录上调 p73 的表达。
PLoS One. 2012;7(8):e43564. doi: 10.1371/journal.pone.0043564. Epub 2012 Aug 30.
5
The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.TFDP1 基因编码 DP1,它是转录因子 E2F 的异二聚体伴侣,是失调 E2F 的一个靶点。
Biochem Biophys Res Commun. 2023 Jun 30;663:154-162. doi: 10.1016/j.bbrc.2023.04.092. Epub 2023 Apr 25.
6
Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.ARF 肿瘤抑制启动子构建介导的肿瘤细胞特异性细胞毒性基因表达。
Biochem Biophys Res Commun. 2014 Jul 18;450(1):240-6. doi: 10.1016/j.bbrc.2014.05.102. Epub 2014 Jun 2.
7
Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.腺病毒E1A癌蛋白通过一种依赖Rb/E2F1的机制降低Bin1表达,从而释放c-Myc活性以促进细胞增殖。
J Cell Physiol. 2008 Sep;216(3):621-31. doi: 10.1002/jcp.21437.
8
E2F-like elements in p27(Kip1) promoter specifically sense deregulated E2F activity.p27(Kip1)启动子中的E2F样元件可特异性感知失调的E2F活性。
Genes Cells. 2009 Jan;14(1):89-99. doi: 10.1111/j.1365-2443.2008.01248.x. Epub 2008 Dec 10.
9
E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.E2F-1转录活性是Mdm2拮抗剂诱导人肿瘤细胞系凋亡的关键决定因素。
Oncogene. 2008 Sep 11;27(40):5303-14. doi: 10.1038/onc.2008.164. Epub 2008 Jun 2.
10
Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.腺病毒12 E1A转录的调控:E1A启动子中的E2F和ATF基序结合包括E2F1、DP-1、细胞周期蛋白A和/或RB在内的核蛋白复合物,并介导转录(自)激活。
Cell Mol Biol Res. 1993;39(8):705-16.

引用本文的文献

1
DEAD/H Box 5 (DDX5) Augments E2F1-Induced Cell Death Independent of the Tumor Suppressor p53.DEAD/H盒蛋白5(DDX5)增强E2F1诱导的细胞死亡,且不依赖于肿瘤抑制因子p53。
Int J Mol Sci. 2024 Dec 10;25(24):13251. doi: 10.3390/ijms252413251.
2
Expanding Roles of the E2F-RB-p53 Pathway in Tumor Suppression.E2F-RB-p53通路在肿瘤抑制中的作用扩展
Biology (Basel). 2023 Dec 11;12(12):1511. doi: 10.3390/biology12121511.
3
Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool.去调控 E2F 活性作为一种肿瘤细胞特异性治疗工具。
Genes (Basel). 2023 Feb 2;14(2):393. doi: 10.3390/genes14020393.
4
Expression and clinical significance of p73 in Wilms tumor in children.p73在儿童肾母细胞瘤中的表达及临床意义
Oncol Lett. 2019 Jun;17(6):5435-5440. doi: 10.3892/ol.2019.10249. Epub 2019 Apr 15.
5
Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes.肿瘤抑制基因和生长相关基因的 E2F 依赖性激活对二聚化伙伴 DP 的不同需求。
Sci Rep. 2018 May 31;8(1):8438. doi: 10.1038/s41598-018-26860-0.